Wall Street analyst estimates for Aclarion, Inc. (ACON): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 0.50 |
Valuation Ratios
| Price / Book | 0.37 |
| EV / EBITDA | 1.68 |
| Dividend Yield | 0.00% |
Price
| Price | $2.55 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of ACON: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks